Print Page   |   Contact Us   |   Your Cart   |   Report Abuse   |   Sign In   |   Apply for NAQC Membership
Site Search
Sign up for NAQC membership today!

Receive a monthly issue of Connections!
NAQC Newsroom: Research

Smoking Termination Opportunity for inPatients (STOP)

Wednesday, November 07, 2012  
Posted by: Natalia Gromov
Superiority of a Course of Varenicline Tartrate Plus Counseling Over Counseling Alone for Smoking Cessation: A 12-month Randomized Controlled Trial for Inpatients.
Smith BJ, Carson KV, Brinn MP, Labiszewski NA, Peters MJ, Fitridge R, Koblar SA, Jannes J, Veale AJ, Goldsworthy SJ, Litt J, Edwards D, Esterman AJ.
Thorax. 2012 Sep 19. [Epub ahead of print]

This study examined the effectiveness of varenicline tartrate plus quitline counseling compared to quitline counseling alone in an inpatient setting. Participants admitted to one of three hospitals with a smoking-related illness were randomized to 12-weeks of varenicline plus quitline counseling or quitline counseling alone, with 12-month follow-up. Results showed that more participants in the varenicline arm remained continuously abstinent (31.1%) than in the counseling only arm (21.4%) (p=0.03). The authors conclude that in an inpatient hospital setting, the combined use of varenicline plus quitline counseling can produce a successful opportunistic treatment for smokers admitted with smoking related illness.

Sign In

Forgot your password?

Not a NAQC Member?

Latest News

Membership 11 years!.

    3219 E. Camelback Road, #416, Phoenix, AZ 85018 | Ph: 800.398.5489 | Fax: 800.398.5489 | email: